Charles River(us:CRL)
145.99
-3.01%
Updated on 2025-04-02
Open:150.81
Close:145.99
High:151.37
Low:145.66
Prev Close:150.52
Volume:1.02M
Turnover:150.27M
Turnover Ratio:1.99%
Shares:51.14M
MarketCap:7.47B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 725 | 52352732 | 101.43% | 73 | 260 | 306 |
| 2024-03-31 | 692 | 51725939 | 100.42% | 87 | 249 | 263 |
| 2023-12-31 | 685 | 52139368 | 101.56% | 88 | 201 | 322 |
| 2023-09-30 | 666 | 51140308 | 99.70% | 80 | 226 | 269 |
| 2023-06-30 | 663 | 50621552 | 98.74% | 66 | 245 | 268 |
| 2023-03-31 | 662 | 50392428 | 98.46% | 69 | 237 | 272 |
| 2022-12-31 | 669 | 49561817 | 97.29% | 107 | 220 | 267 |
| 2022-09-30 | 668 | 49755959 | 97.80% | 60 | 234 | 298 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Vanguard Group Inc | 6103449 | 11.83% | 56982 | 0.94% |
| 2024-06-30 | Blackrock Inc. | 5088017 | 9.86% | -83767 | -1.62% |
| 2024-06-30 | State Street Corp | 2088858 | 4.05% | -5254 | -0.25% |
| 2024-06-30 | Kayne Anderson Rudnick Investment Management Llc | 1908989 | 3.70% | 31359 | 1.67% |
| 2024-06-30 | Clearbridge Investments, Llc | 1368505 | 2.65% | -144633 | -9.56% |
| 2024-06-30 | Allspring Global Investments Holdings, Llc | 1251618 | 2.42% | 132802 | 11.87% |
| 2024-06-30 | Geode Capital Management, Llc | 1216793 | 2.36% | 30949 | 2.61% |
| 2024-06-30 | Meritage Group Lp | 1182657 | 2.29% | 389 | 0.03% |
| 2024-06-30 | Southpoint Capital Advisors Lp | 1150000 | 2.23% | 450000 | 64.29% |
| 2024-06-30 | Earnest Partners Llc | 1004486 | 1.95% | 110725 | 12.39% |
About
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Address:251 Ballardvale Street
Website:http://www.criver.com
Market Movers